Found 445 matching trials
Improving Hypertension Control in Safety-Net Settings: The Boston Hypertension Equity Alliance in Treatment NA High blood pressure (BP) or hypertension (HTN) affects over 100 million ind...
Show More Location
Boston Healthcare for the Homeless (BHCHP)
Learn More & Join Trial
Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs) PHASE2 This is a Phase II, open-label multicentre, randomised study to assess the ...
Show More Location
Hospices Civils de Lyon
Learn More & Join Trial
Hepatitis C Treatment in PWIDs: MAT or Syringe Exchange Assisted-therapy vs Standard of Care PHASE4 hepatitis C virus (HCV) has traditionally been treated in subspecialty heal...
Show More Learn More & Join Trial
Study to Evaluate the Use of Resources and the Costs Associated With Carcinoid Syndrome (CS) in Patients With NETs in Spain N/A The objective of this study is to describe the use of resources and the cos...
Show More Location
Hospital General Univ. de Elche
Learn More & Join Trial
Post-Authorization Safety Study (PASS) of LysaKare® in Adult Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients PHASE4 The purpose of the study was to evaluate the effect of arginine/lysine solu...
Show More Location
Istituto Europeo di Oncologia
Learn More & Join Trial
Combination of Lanreotide Autogel 120mg and Temozolomide in Progressive GEP-NET PHASE2 The purpose of the study is to evaluate the efficacy and tolerability of th...
Show More Location
Vienna General Hospital
Learn More & Join Trial
Cabozantinib in Combination With Avelumab in Patients Refractory to Standard Chemotherapy With Advanced Neuroendocrine Neoplasias G3 (NEN G3) PHASE2 The purpose of the CaboAveNEC trial is to investigate the clinical activity...
Show More Location
Nationales Centrum für Tumorerkrankungen, Universitätsklinikum Heidelberg
Learn More & Join Trial
A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone in Patients With Hypertension and Chronic Kidney Disease PHASE3 A study Comparing the Clinical Benefit of Finerenone Versus a Fixed-Dose Co...
Show More Location
Sarfez Pharmaceuticals, Inc.
Learn More & Join Trial
Explore the Clinical Value of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in Neuroendocrine Neoplasms N/A 68Ga-DOTANOC and 18F-FDG PET/CT have important values in the staging and cl...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Buikwe Electronic Community Health Information System Impact Study NA The purpose of the study is to investigate the impact of the eCHIS interven...
Show More Learn More & Join Trial